SCYNEXIS, Inc. Accrued Liabilities, Current
SCYNEXIS, Inc. (SCYX) had Accrued Liabilities, Current of $2.03 million as of 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current › Accounts Payable and Accrued Liabilities, Current
us-gaap:AccruedLiabilitiesCurrent · last filed 2026-08-10
- 2026-06-30: Accrued Liabilities, Current $2.03M.
- 2026-03-31: Accrued Liabilities, Current $1.53M.
- 2025-12-31: Accrued Liabilities, Current $2.79M.
- 2025-09-30: Accrued Liabilities, Current $2.77M.
| Period end | Accrued Liabilities, Current | Accrued Liabilities, Current as first filed |
|---|---|---|
| 2026-06-30 | $2.03M 10-Q · filed 2026-08-10 | |
| 2026-03-31 | $1.53M 10-Q · filed 2026-05-11 | |
| 2025-12-31 | $2.79M 10-Q · filed 2026-08-10 | |
| 2025-09-30 | $2.77M 10-Q · filed 2025-11-05 | |
| 2025-06-30 | $2.48M 10-Q · filed 2025-08-13 | |
| 2025-03-31 | $2.63M 10-Q · filed 2025-05-15 | |
| 2024-12-31 | $3.79M 10-K · filed 2026-03-04 | |
| 2024-09-30 | $5.51M 10-Q · filed 2024-11-06 | |
| 2024-06-30 | $5.50M 10-Q · filed 2024-08-08 | |
| 2024-03-31 | $4.60M 10-Q · filed 2024-05-08 | |
| 2023-12-31 | $7.50M 10-K · filed 2025-03-12 | |
| 2023-09-30 | $9.54M 10-Q · filed 2023-11-13 | |
| 2023-06-30 | $7.19M 10-Q · filed 2023-08-14 | |
| 2023-03-31 | $4.78M 10-Q · filed 2023-05-10 | |
| 2022-12-31 | $5.63M 10-K · filed 2024-03-28 | |
| 2022-09-30 | $5.86M 10-Q · filed 2022-11-09 | |
| 2022-06-30 | $5.40M 10-Q · filed 2022-08-15 | |
| 2022-03-31 | $4.52M 10-Q · filed 2022-05-12 | |
| 2021-12-31 | $5.70M 10-K · filed 2023-03-31 | |
| 2021-09-30 | $4.61M 10-Q · filed 2021-11-10 | |
| 2021-06-30 | $3.37M 10-Q · filed 2021-08-16 | |
| 2021-03-31 | $2.13M 10-Q · filed 2021-05-17 | |
| 2020-12-31 | $4.14M 10-K · filed 2022-03-29 | |
| 2020-09-30 | $3.00M 10-Q · filed 2020-11-06 | |
| 2020-06-30 | $2.39M 10-Q · filed 2020-08-10 | |
| 2020-03-31 | $1.79M 10-Q · filed 2020-05-11 | |
| 2019-12-31 | $3.80M 10-K · filed 2021-03-29 | |
| 2019-09-30 | $2.24M 10-Q · filed 2019-11-12 | |
| 2019-06-30 | $3.41M 10-Q · filed 2019-08-07 | |
| 2019-03-31 | $2.21M 10-Q · filed 2019-05-08 | |
| 2018-12-31 | $2.10M 10-K · filed 2020-03-11 | |
| 2018-09-30 | $1.40M 10-Q · filed 2018-11-13 | |
| 2018-06-30 | $1.62M 10-Q · filed 2018-08-09 | |
| 2018-03-31 | $937.00K 10-Q · filed 2018-05-08 | |
| 2017-12-31 | $1.71M 10-K · filed 2019-03-14 | |
| 2017-09-30 | $1.74M 10-Q · filed 2017-11-07 | |
| 2017-06-30 | $1.33M 10-Q · filed 2017-08-08 | |
| 2017-03-31 | $1.06M 10-Q · filed 2017-05-08 | |
| 2016-12-31 | $1.27M 10-K · filed 2018-03-13 | |
| 2016-09-30 | $1.31M 10-Q · filed 2016-11-07 | |
| 2016-06-30 | $2.91M 10-Q · filed 2016-08-08 | |
| 2016-03-31 | $2.57M 10-Q · filed 2016-05-09 | |
| 2015-12-31 | $3.15M 10-K · filed 2017-03-13 | |
| 2015-09-30 | $1.54M 10-Q · filed 2015-11-13 | |
| 2015-06-30 | $2.83M 10-Q · filed 2015-08-19 | |
| 2015-03-31 | $3.06M 8-K · filed 2015-10-30 | $3.28M 10-Q · filed 2015-05-15 |
| 2014-12-31 | $2.25M 10-K · filed 2016-03-07 | $2.50M 10-K · filed 2015-03-30 |
| 2014-09-30 | $2.02M 10-Q · filed 2014-11-13 | |
| 2014-06-30 | $2.51M 10-Q · filed 2014-08-13 | |
| 2014-03-31 | $1.60M 10-Q/A · filed 2014-07-11 | |
| 2013-12-31 | $732.00K 8-K · filed 2015-10-30 | $1.06M 10-Q/A · filed 2014-07-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PDS Biotechnology Corp (PDSB) | United States | $0.045B | |
| Grace Therapeutics, Inc. (GRCE) | $0.046B | -1.83 | |
| VERU INC. (VERU) | United States | $0.043B | -3.93 |
| Werewolf Therapeutics, Inc. (HOWL) | United States | $0.047B | |
| Kairos Pharma, LTD. (KAPA) | United States | $0.041B | |
| Dogwood Therapeutics, Inc. (DWTX) | United States | $0.049B | |
| Lite Strategy, Inc. (LITS) | United States | $0.049B | |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| Elicio Therapeutics, Inc. (ELTX) | United States | $0.049B | |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |